“You may choose to look the other way, but you can never say again that you did not know.”
— William Wilberforce
A student at Union College was unenrolled and forced to leave the campus in upstate New York after she refused to take a COVID-19 booster shot. The pre-med biology and Spanish language student suffered severe adverse reactions after receiving the first series of Pfizer/BioNTech COVID shots in the fall.1 Sophomore Ellie Puentes is a first-generation […]
Opinion | A new CDC study shows that around 75% of American children have already had COVID-19. That means that they have strong natural immunity that protects them from SARS-CoV-2 infections as they get older. Despite this, the CDC, the FDA and other government agencies are pushing all of them to get vaccinated. Why? One […]
Following the granting by the U.S. Food and Drug Administration (FDA) of Emergency Use Authorization (EUA) status for Pfizer/BioNTech’s BNT162b2 and Moderna/NIAID’s mRNA-1273 messenger RNA (mRNA) COVID-19 biologics in December 2020, there have been increasing reports of alopecia areata following vaccination with these products.1 Alopecia areata is an autoimmune disorder characterized by hair loss due […]
As COVID-19 vaccine sales continue to soar, Moderna Chief Executive Stephane Bancel’s total personal financial compensation increased by 41 percent in 2021, reaching $18.2 million. The company’s total revenue rose 2,200 percent in 2021, jumping from $803 million to $18.5 billion.1 2 Moderna partnered with the National Institute of Allergy and Infectious Diseases (NIAID), headed […]
Moderna, Inc., developer of the experimental messenger RNA (mRNA) mRNA-1273, or “Spikevax,” biologic, has recalled 764,900 doses in lot #000190A of the product from the European market. On Apr. 8, 2022, the company said that the doses, manufactured under contract to Moderna by Spanish pharmaceutical company ROVI Pharma Industrial Services, SAU, are being pulled out […]
On Mar. 29, 2022, the U.S. Food and Drug Administration (FDA) approved a second booster dose (a fourth shot) of the Pfizer/BioNTech messenger RNA (mRNA) biologic BNT162b2 (“Comirnaty”) and Moderna/NIAID mRNA-1273 (“Spikevax”) for people 50 years of age and older, as well as younger individuals who are immunocompromised. The second booster would be given no […]
Hospitalizations for COVID-19 have been declining throughout the United States during the past month. On Feb. 9, 2022, CNN reported that, according to the U.S. Department of Health and Human Services (DHSS), the number of beds being used by COVID patients had dropped by 38 percent to under 100,000 from two weeks prior when COVID […]
Four cases of an autoimmune bleeding disorder known as acquired hemophilia (AHA) were diagnosed in Italy’s northern province of Reggio Emilia weeks after the individuals received Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 (also known as “Comirnaty”) biologic. The report about these four cases was published in a letter to the editors of journal Thrombosis Research […]
A U.S. cohort study assessing the effect of COVID-19 shots on menstrual cycles was peer reviewed and published in the journal Obstetrics & Gynecology on Jan. 5, 20221 after many women spoke out about changes to their menstrual cycles after receiving COVID shots. The U.S. National Institutes of Health (NIH) provided $1.6 million to fund […]
A new study published in the journal JAMA Otolaryngology-Head & Neck Surgery published on Feb. 24, 2022 has found a possible association between Pfizer/BioNTech’s BNT162b2 (also known as “Comirnaty”) messenger RNA (mRNA) COVID-19 biologic and sudden sensorineural hearing loss (SSNHL). The retrospective cohort study of 2 ,602, 557 patients in Israel suggested a slight increased risk of SSNHL.1 […]